Trials / Completed
CompletedNCT01949779
TransForm™ Occlusion Balloon Catheter Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 81 (actual)
- Sponsor
- Stryker Neurovascular · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this registry is to collect real world data on the safety and performance of the TransForm™ Occlusion Balloon Catheter when used in current neurointerventional procedures
Detailed description
* This is a prospective, single-arm, non-randomized, multi-center, observational registry. * The expected duration for study enrollment is approximately 6 months-1 year. * Study participation for each subject will be completed upon removal of the guide catheter post-procedure. * Up to 140 subjects will be enrolled at up to 15 study sites. A given site will be allowed to enroll a maximum of 20 subjects. * Enrollment in the registry occurs after a signed Informed Consent Form has been obtained, and the index procedure starts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TransForm™ Occlusion Balloon Catheter | TransForm™ Occlusion Balloon Catheter |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2013-09-25
- Last updated
- 2019-09-06
- Results posted
- 2019-08-19
Locations
7 sites across 2 countries: United States, Spain
Source: ClinicalTrials.gov record NCT01949779. Inclusion in this directory is not an endorsement.